Table 2.
Laboratory data before HSCT and after HSCT at diagnosis of FS
| Laboratory parameter (reference range) | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|
| Before HSCT | |||||
| Kappa light chain (0.33–1.94 mg/dl) | 4.8 | 1.71 | 0.678 | <0.0061 | 57.7 |
| Na+ (135–145 mmol/l) | 142 | 137 | 141 | 142 | 145 |
| K+ (3.6–5.2 mmol/l) | 3.8 | 5.2 | 4.6 | 4.5 | 3.7 |
| Cl− (98–107 mmol/l) | 100 | 103 | 101 | 102 | 104 |
| HCO3− (22–29 mmol/l) | 33 | 23 | 28 | 24 | 22 |
| Anion gap (7–15) | 9 | 11 | 12 | 16 | 19 |
| Mg2+ (1.7–2.3 mg/dl) | 1.5 | 1.5 | 1.9 | 1.6 | 1.7 |
| PO43− (2.5–4.5 mg/dl) | 4.4 | 4.8 | 2.5 | 3 | 3.3 |
| Uric acid (3.7–8.0 mg/dl) | 7.6 | 9.9 | 4.7 | N/A | 4.2 |
| Creatinine (0.74–1.35 mg/dl) | 1.1 | 1.7 | 0.9 | 0.77 | 1.7 |
| Creatinine-based eGFR (≥60 ml/min/BSA) | 54 | 41 | 67 | 105 | 42 |
| Glucose (70–140 mg/dl) | 99 | 124 | 116 | 86 | 140 |
| Urine glucose (0–15 mg/dl) | 4 | 19 | 17 | 17 | 22 |
| Predicted 24-hour urine total protein (mg) | 112 | 696 | 166 | 361 | 2706 |
| After HSCT at diagnosis of FS | |||||
| Kappa light chain (0.33–1.94 mg/dl) | 14 | 0.374 | 2.23 | 0.0483 | 28.5 |
| Na+ (135–145 mmol/l) | 140 | 140 | 143 | 135 | 141 |
| K+ (3.6–5.2 mmol/l) | 3.2 | 4.6 | 2.6 | 3.3 | 3.2 |
| Cl− (98–107 mmol/l) | 111 | 116 | 103 | 107 | 116 |
| HCO3− (22–29 mmol/l) | 19 | 17 | 26 | 16 | 13 |
| Anion gap (7-15) | 10 | 7 | 14 | 12 | 12 |
| Mg2+ (1.7–2.3 mg/dl) | 1.3 | 1.6 | 1.6 | 1.3 | 1.5 |
| PO43− (2.5–4.5 mg/dl) | 1.9 | 3.3 | 1 | 1.1 | 1 |
| Uric acid (3.7–8.0 mg/dl) | N/A | 7.8 | 1.5 | 1.3 | 4.6 |
| Creatinine (0.74–1.35 mg/dl) | 2.2 | 3.4 | 0.6 | 1.01 | 2.07 |
| Creatinine-based eGFR (≥60 ml/min/BSA) | 25 | 18 | 67 | 86 | 33 |
| Glucose (70–140 mg/dl) | 91 | N/A | 121 | 83 | 126 |
| Urine glucose (0–15 mg/dl) | 26 | 26 | 151 | 306 | 12 |
| Predicted 24-hour urine total protein, mg | 1848 | 846 | 857 | 2350 | 1540 |
| Random urine electrolytes | |||||
| Na+, mmol/l | 117 | N/A | 140 | N/A | 37 |
| K+, mmol/l | 30 | 14 | 33 | ||
| Cl−, mmol/l | 135 | 90 | 32 | ||
| Mg2+, mg/dl | 49 | ||||
| PO43−, mg/dl | 66 | ||||
| Creatinine, mg/dl | 62 | 64 | 89 | ||
| Urine anion gap | 50 | N/A | N/A | 30 | 38 |
| Random urine K+/creatinine ratio,a mEq/mmol | 5.47 | N/A | 2.5 | N/A | 4.19 |
| FeMg2+, % | N/A | N/A | 4b | N/A | N/A |
| FePO43-, % | N/A | N/A | 61.88c | N/A | N/A |
| 24-hour urine electrolytes | |||||
| Na+ (41–227 mmol/day) | N/A | N/A | N/A | 338 | N/A |
| K+ (17–77 mmol/day) | 109d | ||||
| Cl− (40–224 mmol/day) | 417 | ||||
| Mg2+ (51–269 mg/day) | 225e | ||||
| PO43− (<1100 mg/day) | 413f | ||||
| Creatinine (601–1689 mg/day) | 1202 | ||||
FS, Fanconi syndrome; HSCT, hematopoietic stem cell transplantation; N/A, not applicable.
A random urine K+/creatinine ratio of >2.5 mEq/mmol suggests inappropriate response by the kidneys to hypokalemia and kidney K+ wasting.
A FeMg2+ of >3% suggests inappropriate response by the kidneys to hypomagnesemia and kidney Mg2+ wasting.
A FePO43−of >5% suggests inappropriate response by the kidneys to hypophosphatemia and kidney PO43− wasting.
A 24-hour urine K+ of >25–30 mmol/day suggests inappropriate response by the kidneys to hypokalemia and kidney K+ wasting.
A 24-hour urine Mg2+ of >10–30 mg/day suggests inappropriate response by the kidneys to hypomagnesemia and kidney Mg2+ wasting.
A 24 hour urine PO43− of >100 mg/day suggests inappropriate response by the kidneys to hypophosphatemia and kidney PO43− wasting.